Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease proteomics.

Sam Hanash1

  • 1Department of Pediatrics, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109, USA. shanash@umich.edu

Nature
|March 14, 2003
PubMed
Summary
This summary is machine-generated.

Proteomics, enabled by genome sequencing, aids disease understanding and drug development. High sensitivity and throughput are key challenges for these vital investigations.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Cancer Immunosurveillance.

Frontiers in immunology·2026
Same author

Rank-based learning: a novel high-throughput algorithm resilient to missing data and effective for datasets with small sample size.

Briefings in bioinformatics·2026
Same author

Breast cancer risk assessment: current challenges and the emerging role of blood-based protein biomarkers.

Journal of the National Cancer Institute·2025
Same author

Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone.

Cancer letters·2024
Same author

Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases.

JNCI cancer spectrum·2024
Same journal

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Nature·2026
Same journal

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Nature·2026
Same journal

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Nature·2026
Same journal

Child online safety needs more than social-media bans.

Nature·2026
Same journal

Ebola preparedness must start with ecosystems and before humans show symptoms.

Nature·2026
Same journal

AI tools can speed up thinking, but evidence still comes from the lab bench.

Nature·2026
See all related articles

Area of Science:

  • Proteomics
  • Genomics
  • Biomarker Discovery

Background:

  • Human and pathogen genome sequencing provides a framework for proteome analysis.
  • Proteomics is increasingly important for understanding disease mechanisms.

Purpose of the Study:

  • To explore the application of proteomics in disease research.
  • To identify opportunities and challenges in high-throughput, sensitive proteomic investigations.

Main Methods:

  • Utilizing sequence-based frameworks from genome data.
  • Applying proteomic techniques for disease-related studies.

Main Results:

  • Genome sequencing facilitates proteomic exploration.
  • Proteomics offers potential for disease understanding, biomarker development, and drug discovery.

Conclusions:

  • Proteomics is a valuable tool for advancing medical research.
  • Meeting high sensitivity and throughput demands is crucial for clinical applications.